Award
NIH Reporter #5K08HL166962-04
Aspirin for Primary Prevention of Cardiovascular Disease in Patients with Elevated Lipoprotein(a)
Recipient
University of California, San Diego
Award Amount
$168,912.00
Ceiling
$168,912.00
Awarded
September 09, 2026
Identifier
5K08HL166962-04
NIH funded project to study low-dose aspirin's effectiveness in preventing cardiovascular disease in patients with high Lipoprotein(a) using existing clinical trial data and cohort studies.
Description
This project aims to evaluate the efficacy of low-dose aspirin therapy in reducing atherosclerotic cardiovascular disease (ASCVD) events among individuals with elevated Lipoprotein(a) [Lp(a)]. The study involves secondary analyses of existing clinical trials (ASCEND and ASPREE) and prospective cohort studies with diverse ethnic populations in the United States.